Home » Topics » BioWorld Science

BioWorld Science
RSS

Elastase inhibition enhances the adjuvant activity of alum for SARS-CoV-2 vaccination

Oct. 1, 2021

Different way of looking allows new insights into cancer biology

Oct. 1, 2021

Antibodies targeting glycosylated CD44 synthesized at Go Therapeutics

Oct. 1, 2021

Identification of novel viral cleavage sites and potential therapeutic targets against SARS-CoV-2

Oct. 1, 2021

Primate model of autism spectrum disorder reveals potential therapeutic targets

Oct. 1, 2021

Kynurenine metabolites as biomarkers of chronic fatigue syndrome and fibromyalgia

Oct. 1, 2021

APMAP identified as a regulator of cancer cell phagocytosis

Oct. 1, 2021

PTGER4 antagonists discovered at Hubei Bio-Pharmaceutical, Humanwell Healthcare

Oct. 1, 2021

Leiden University and collaborators patent monoglyceride lipase inhibitors

Oct. 1, 2021

New antivirals presented by EcoSynth, Transmare Chemie

Oct. 1, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...